Researchers at the University at Buffalo are hard at work studying rare diseases and caring for the many patients suffering from them. UB will hold an event recognizing rare disease patients, their clinicians and the researchers working to discover causes — and ultimately cures — for these conditions.
Brian H. Williams, MD, a Black, Harvard-trained trauma surgeon, would love to put himself out of a job so he never has to tell another mother their child has died due to gun violence.
Rice cereal, formula, purees and puffs. They’re among the most popular products purchased from the baby food aisle. And they share one more thing in common: They likely contain toxic metals.
A new Jacobs School of Medicine and Biomedical Sciences study conducted at Oishei Children’s Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in children (MIS-C) during the omicron wave of the pandemic than the delta wave.
“I don’t feel that we can talk about gun violence in this country without talking about race,” he said. “Why do I say that? We need to look at who is harmed by gun violence and who is protected. Which stories are elevated and which are minimized.”
Getting a paper published in the New England Journal of Medicine (NEJM) is a career-crowning achievement for any medical researcher. This fall, within one week, it happened to two members of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences, both of whom also happen to be Jacobs School alumnae.
Nineteen faculty members with clinical and research experience have joined the departments of Medicine, Obstetrics and Gynecology, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, and Physiology and Biophysics.
As the holiday season kicks into high gear, Jacobs School of Medicine and Biomedical Sciences physicians and scientists have recommendations for how people can stay safe and healthy this holiday season amid some increasingly concerning signs.
For teens who have struggled with obesity, it probably sounded too good to be true: a weekly injection that could help them control their eating and lead to weight loss. But the results of the clinical trial on the drug semaglutide, released earlier this month in the New England Journal of Medicine and presented at the discipline’s major conference, Obesity Week, turned out to be better than anything the participants — or even the researchers — expected.
The request by children’s hospitals nationwide this month that the federal government declare a formal state of emergency given the surge in respiratory syncytial virus (RSV) and flu cases was no surprise to Oscar G. Gómez, MD, PhD, associate professor of pediatrics.
